Heterocyclo-substituted azabicyclo muscannic agonists

Details Heterocyclo-substituted azabicyclo muscannic agonists Heterocyclo-substituted azabicyclo muscannic agonists

1989-03-07

1990-11-06

Lee, Mary C.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514299, 514361, 514363, 514363, 514364, 514365, 514372, 514374, 514378, 514397, 514406, 546112, 546133, 548127, 548128, 548131, 548134, 548136, 548181, 548214, 548235, 548247, 548336, 548374, A61K 3133, C07D41714, C07D41314

Patent

active

049686917

ABSTRACT:
A compound of formula (I) or a pharmaceutically acceptable salt thereof: ##STR1## in which X represents a group ##STR2## in which p represents an integer of 2 to 4; r represents an integer of 1 or 2; s represents 0 or 1; and A represents a 3-membered divalent residue completing a 5-membered aromatic ring and comprises one or two heteroatoms selected from oxygen, nitrogen and sulphur, any amino nitrogen optionally substituted by a C.sub.1-4 alkyl group, and when (p,r,s) is (2,2,0) or (2,2,1) any A comprising 2 heteroatoms is optionally C-substituted by a methyl group, and when (p,r,s) is (2,1,0), (2,1,1) or (3,1,0) any A comprising 2 heteroatoms is optionally C-substituted by C.sub.1-2 alkyl and any A comprising one heteroatom is optionally C-substituted by a methyl group, and wherein compounds of formula (I) having two asymetric centers have the stereo-chemical configuration in which the group X and the (CH.sub.2).sub.r bridge are on the same side of the plane of the molecule which contains both bridgehead atoms and the ring carbon atom bonded to the group X. The compounds of the present invention enhance acetylcholine function via an action at muscarinic receptors within the central nervous system and are therefore of potential use in the treatment and/or prophylaxis of dementia in mammals.

REFERENCES:
patent: 2658067 (1953-11-01), Duschinsky
patent: 3501471 (1970-03-01), Remers et al.
patent: 3681363 (1972-08-01), Elkin et al.
patent: 4038402 (1977-07-01), Kaminka et al.
patent: 4203990 (1980-05-01), Yen
H. S. Aaron et al., J. Amer. Chem. Soc., 89, pp. 1431-1437 (1967).
G. Lambrecht and E. Mutschler, Drug Res., 24, p. 1725 (1975).
C. A. Grob and E. Renk, Helv. Chim. Acta., 37, pp. 1689 (1954).
M. J. Martell and T. O. Soine, J. Pharm. Sci., 52, pp. 331-336 (1963).
M. D. Mashkovsky, Proc. 1st Int. Pharmacol. Meet., 7, pp. 359-366 (1963).
D. Spry and H. S. Aaron, J. Org. Chem., 84, pp. 3674-3676 (1969).
L. H. Sternbach and S. Kaiser, J. Amer. Chem. Soc., 74, pp. 2219-2221 (1952) ("Sternbach-I").
L. H. Sternbach and S. Kaiser, J. Amer. Chem. Soc., 74, pp. 2215-2218 (1952) ("Sternbach-II").
B. P. Thill et al., "Azabicyclic Alcohols. V.", Chem. Abs., vol. 70:11 (Mar. 17, 1969): J. Org. Chem., 33:12, pp. 4376-4380 (1968).
K. A. Zaitseva et al., Chem. Abs., vol. 62:11 (May 24, 1965): Farmakol. i Toksikol., 27:6, pp. 686-690 (1964).
J. E. Christie, et al., Brit. J. Psychiat., 138, pp. 46-50 (1981).
P. T. Francis, et al., N. Engl. J. Med., 313, pp. 7-11 (1985).
E. Hollander, et al., Brit. Med. Bull., 42, pp. 97-100 (1986).
E. K. Perry, et al., Can. J. Neurol. Sci., 13, pp. 521-527 (1986).
R. Peterson, Psychopharmacology, 52, pp. 283-289 (1977).
Sitaram, et al., Science, 201, p. 274 (1978).
Office of Technology Assessment, Publication No. OTA-BA-323 (Washington, D.C: U.S. Government Printing Office) Apr. 1987, pp. 59-62, 104-105.

Affiliated with

Also associated with

Rating

Heterocyclo-substituted azabicyclo muscannic agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Heterocyclo-substituted azabicyclo muscannic agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclo-substituted azabicyclo muscannic agonists will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1307056